Peptides for Cognitive Enhancement? | The Gillett Health Podcast #41
About this video
Gillett examines marketing for dihexa as a cognitive-enhancement peptide and argues the claims far exceed the evidence. He notes the compound is described as an angiotensin-related analog and questions promotional framing that presents effects on aldosterone and sodium retention as positives, when he argues they could point toward blood-pressure concerns. He says the human-sounding claims about memory, Alzheimer’s and synapse restoration rest largely on cell and rodent work, including maze studies in impaired rats, rather than conclusive human trials. He contrasts this with better-supported cognition basics such as sleep and lifestyle, and says he would not recommend dihexa.
Key takeaways
- Extraordinary cognition claims require human trial evidence, not rodent or cell data
- Marketing can frame a physiological effect as positive when it may signal risk
- Gillett argues dihexa has not progressed to conclusive neuroprotective evidence
- Sleep, diet and attention habits remain the foundation he points to first
- Watch for websites that say patients will feel benefits without citing human studies
Episode details: published March 31, 2023 · 7.1K views · 4:54 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.
← Previous: Research Peptides | The Gillett Health Podcast #31 · Next: All Things Peptides | The Gillett Health Podcast #31 →
All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)
